Cargando…
Quality and utility of [(123)I]I-metaiodobenzylguanidine cardiac SPECT imaging in nondiabetic postinfarction heart failure patients qualified for implantable cardioverter defibrillator
OBJECTIVE: Impaired cardiac adrenergic activity has been demonstrated in heart failure (HF) and in diabetes mellitus (DM). [(123)I]I-metaiodobenzylguanidine (MIBG) enables assessment of the cardiac adrenergic nervous system. Tomographic imaging of the heart is expected to be superior to planar imagi...
Autores principales: | Teresińska, Anna, Woźniak, Olgierd, Maciąg, Aleksander, Wnuk, Jacek, Jezierski, Jarosław, Fronczak, Aneta, Biernacka, Elżbieta Katarzyna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Singapore
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8285320/ https://www.ncbi.nlm.nih.gov/pubmed/34023989 http://dx.doi.org/10.1007/s12149-021-01628-1 |
Ejemplares similares
-
Iodine-123-metaiodobenzylguanidine cardiac SPECT imaging in the qualification of heart failure patients for ICD implantation
por: Teresińska, Anna
Publicado: (2018) -
Convolutional neural network-based automatic heart segmentation and quantitation in (123)I-metaiodobenzylguanidine SPECT imaging
por: Saito, Shintaro, et al.
Publicado: (2021) -
(123)I‐Metaiodobenzylguanidine Myocardial Scintigraphy in Discriminating Degenerative Parkinsonisms
por: Catalan, Mauro, et al.
Publicado: (2021) -
(123)I metaiodobenzylguanidine (MIBG) uptake predicts early relapse of neuroblastoma using semi-quantitative SPECT/CT analysis
por: Kitamura, Yoshiyuki, et al.
Publicado: (2021) -
Three-Dimensional Heart Segmentation and Absolute Quantitation of Cardiac (123)I-metaiodobenzylguanidine Sympathetic Imaging Using SPECT/CT
por: Saito, Shintaro, et al.
Publicado: (2023)